arrow
Return

Evolutionary reversion in tumorigenesis

delete2023-11-07
delete3
delete
OA
AI
Y
Yosuke Nagahata
H
Hiroshi Kawamoto *
DOI:10.3389/fonc.2023.1282417delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Cells forming malignant tumors are distinguished from those forming normal tissues based on several features: accelerated/dysregulated cell division, disruption of physiologic apoptosis, maturation/differentiation arrest, loss of polarity, and invasive potential. Among them, accelerated cell division and differentiation arrest make tumor cells similar to stem/progenitor cells, and this is why tumorigenesis is often regarded as developmental reversion. Here, in addition to developmental reversion, we propose another insight into tumorigenesis from a phylogeny viewpoint. Based on the finding that tumor cells also share some features with unicellular organisms, we propose that tumorigenesis can be regarded as evolutionary reversion. Recent advances in sequencing technologies and the ability to identify gene homologous have made it possible to perform comprehensive cross-species transcriptome comparisons and, in our recent study, we found that leukemic cells resulting from a polycomb dysfunction transcriptionally resemble unicellular organisms. Analyzing tumorigenesis from the viewpoint of phylogeny should reveal new aspects of tumorigenesis in the near future, and contribute to overcoming malignant tumors by developing new therapies.
Keywords:
tumorigenesis
evolution
unicellular organism
multicellularization
cross-species comparison
transcriptome
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Frontiers in Oncology cover
Frontiers in Oncology
IF:
3.3
Papers:
3.5W
Citations:
9.5W

Organization

K
Kyoto University
Scholars:
5.1W
Papers: 4.6W
Citations: 6.1W